Opinion: Time to explore a new vaccine, booster for tuberculosis
By K Leelamoni April 30, 2024: Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent — next to.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
By K Leelamoni April 30, 2024: Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent — next to.
HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in.
Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a.
HQ Team September 23, 2023: The WHO’s rapid test will be used as the first method to diagnose tuberculosis and the global health.
HQ Team June 30, 2023: Two philanthropic health majors, Wellcome and the Bill & Melinda Gates Foundation, have come together to invest around.
Tuberculosis, the second deadliest infectious killer after Covid-19, claimed 1.6 million lives last year, including 187,000 HIV-positive patients, according to the WHO's 2022.